Circulating CD40 ligand in peripheral arterial disease

Thrombosis Research

Volumn 120, Issue 5, 2007, Pages 781-782

  Moresco, Rafael Noal ^a   de Bem, Andreza Fabro ^a   da Silva, José Edson Paz ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; D DIMER; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTERY OCCLUSION; ATHEROSCLEROSIS; DISEASE MARKER; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYMPTOM;

ANGIOGRAPHY; ANTITHROMBINS; ATHEROSCLEROSIS; CD40 LIGAND; ENDOTHELIAL CELLS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION; INTERLEUKIN-6; PERIPHERAL VASCULAR DISEASES; PROTEIN-TYROSINE KINASES; THROMBIN;

EID: 34547943067     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.03.003     Document Type: Letter

References (12)

1. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
2. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary case. JAMA 286 (2001) 1317-1324
3. McDermott M.M., Kerwin D.R., Liu K., Martin G.J., O'Brien E., Kaplan H., et al. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med 16 (2001) 384-390
4. McDermott M.M., Greenland P., Liu K., Guralnik J.M., Celic L., Criqui M.H., et al. The ankle brachial index as a measure of leg functioning and physical activity in peripheral arterial disease: the Walking and Leg Circulation Study. Ann Intern Med 136 (2002) 873-883
5. Chen K., Huang J., Gong W., Zhang L., Yu P., and Wang J.M. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system. Cell Mol Immunol 3 (2006) 163-169
6. Andre P., Mannizzi-Alaimo L., Prasad S.K., and Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106 (2002) 896-899
7. Lee W.J., Sheu W.H., Chen Y.T., Liu T.J., Liang K.W., Ting C.T., et al. Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases. Thromb Res 118 (2006) 619-626
8. McDermott M.M., Greenland P., Green D., Guralnik J.M., Criqui M.H., Liu K., et al. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 107 (2003) 3191-3198
9. Lowe G.D.O., Rumley A., McMahon A.D., Ford I., O'Reilly D.S.J., and Packard C.J. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol 24 (2004) 1529-1534
10. Nylaende M., Kroese A., Stranden E., Morken B., Sandbaek G., Lindahl A.K., et al. Markers of vascular inflammation are associated with the extend of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial disease. Vasc Med 11 (2006) 21-28
11. Nylaende M., Kroese A., Stranden E., Morken B., Sandbaek G., Lindahl A.K., et al. Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease. Thromb Haemost 95 (2006) 702-707
12. Roy D., Quiles J., Sharma R., Sinha M., Avanzas P., Gaze D., et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 50 (2004) 1656-1660